How can Baxter International address the recent 20% increase in customer complaints related to its Floseal Hemostatic Matrix product?

Introduction

Addressing the 20% increase in customer complaints for Baxter International's Floseal Hemostatic Matrix requires a systematic approach to identify and resolve the root cause. As we delve into this analysis, we'll focus on understanding the product, breaking down the metric, generating hypotheses, and developing a comprehensive resolution plan.

Step 1

Clarifying Questions (3 minutes)

• Looking at the timing, I'm thinking there might be a recent change in the product or manufacturing process. Has there been any significant alteration to Floseal's formulation or production in the last 3-6 months?

Why it matters: Recent changes could directly correlate with the increase in complaints. Expected answer: Yes, there was a minor change in the manufacturing process. Impact on approach: If confirmed, we'd focus on the specific change and its potential effects.

• Considering the nature of Floseal, I'm wondering about the types of complaints we're seeing. Are these complaints primarily related to efficacy, ease of use, or potential side effects?

Why it matters: The nature of complaints guides our investigation and solution development. Expected answer: Complaints are mostly about reduced efficacy in stopping bleeding. Impact on approach: We'd prioritize examining the product's hemostatic properties and application process.

• Given the medical nature of Floseal, I'm curious about regulatory oversight. Have there been any recent FDA inspections or changes in regulatory requirements that might impact our product?

Why it matters: Regulatory changes could necessitate product adjustments that might affect performance. Expected answer: No recent regulatory changes specific to Floseal. Impact on approach: We'd focus more on internal factors rather than regulatory compliance issues.

• Thinking about our user base, I'm wondering if the complaints are concentrated in a particular geographic region or healthcare setting. Do we see any patterns in the distribution of these complaints?

Why it matters: Localized issues might indicate problems with specific batches or regional factors. Expected answer: Complaints are fairly evenly distributed across regions and settings. Impact on approach: We'd look at global factors affecting the product rather than localized issues.